全文获取类型
收费全文 | 81篇 |
免费 | 3篇 |
出版年
2022年 | 1篇 |
2020年 | 2篇 |
2019年 | 2篇 |
2018年 | 1篇 |
2016年 | 1篇 |
2015年 | 3篇 |
2014年 | 3篇 |
2013年 | 9篇 |
2012年 | 4篇 |
2011年 | 3篇 |
2010年 | 2篇 |
2009年 | 2篇 |
2008年 | 3篇 |
2007年 | 4篇 |
2006年 | 1篇 |
2005年 | 5篇 |
2004年 | 3篇 |
2003年 | 7篇 |
2002年 | 5篇 |
2001年 | 1篇 |
2000年 | 2篇 |
1999年 | 5篇 |
1996年 | 1篇 |
1995年 | 1篇 |
1994年 | 2篇 |
1993年 | 2篇 |
1991年 | 2篇 |
1990年 | 1篇 |
1983年 | 1篇 |
1982年 | 1篇 |
1978年 | 1篇 |
1975年 | 1篇 |
1971年 | 1篇 |
1967年 | 1篇 |
排序方式: 共有84条查询结果,搜索用时 78 毫秒
71.
Danilenko N Merkulava E Siniauskaya M Olejnik O Levaya-Smaliak A Kushniarevich A Shymkevich A Davydenko O 《PloS one》2012,7(5):e36354
The genetic nature of sensorineural hearing loss (SNHL) has so far been studied for many ethnic groups in various parts of the world. The single-nucleotide guanine deletion (35delG) of the GJB2 gene coding for connexin 26 was shown to be the main genetic cause of autosomal recessive deafness among Europeans. Here we present the results of the first study of GJB2 and three mitochondrial mutations among two groups of Belarusian inhabitants: native people with normal hearing (757 persons) and 391 young patients with non-syndromic SNHL. We have found an extremely high carrier frequency of 35delG GJB2 mutation in Belarus -5.7%. This point deletion has also been detected in 53% of the patients with SNHL. The 312del14 GJB2 was the second most common mutation in the Belarus patient cohort. Mitochondrial A1555G mt-RNR1 substitution was found in two SNHL patients (0.55%) but none were found in the population cohort. No individuals carried the A7445G mutation of mitochondrial mt-TS1. G7444A as well as T961G substitutions were detected in mitochondrial mt-RNR1 at a rate of about 1% both in the patient and population cohorts. A possible reason for Belarusians having the highest mutation carrier frequency in Europe 35delG is discussed. 相似文献
72.
łuczyński W Kowalczuk O Iłendo E Stasiak-Barmuta A Krawczuk-Rybak M Malinowska I Kołtan A Szczepalński T Olejnik I Jaworowski R Chyczewski L Matysiak M Wysocki M Sońta-Jakimczyk D Wieczorek M 《Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society》2007,45(1):15-20
The use of cancer vaccines based on dendritic cells (DC) presenting tumor antigens can be a promising tool in the treatment of leukemia. The functional characteristics of leukemia derived DC is still to be elucidated. CD40 promotes survival, proliferation and differentiation of normal B cells. CD40 triggering was used to enhance the poor antigen-presenting capacity of leukemic B-cells. Since it is still unclear whether CD40 ligation drives neoplastic B-cells to apoptosis or not, we assessed the mRNA expression of FLICE, FAS, FADD and TRADD - important components of apoptosis machinery, using real-time PCR in acute lymphoblastic leukemia cells before and after CD40 and IL-4 stimulation. ALL cells stimulated with CD40L/IL-4 expressed dendritic cell phenotype at mRNA and protein levels (upregulation of main costimulatory and adhesion molecules noted in real-time RT PCR and flow cytometry); they also expressed higher amounts of mRNA for FLICE, TRADD and FADD after CD40L/IL-4 stimulation. However differences statistically significant comparing cells cultured with CD40L/IL-4 and medium alone regarded only FLICE. Concluding, we showed upregulation of important elements of apoptosis at mRNA level in ALL cells after CD40 ligation. 相似文献
73.
Roger V. Lebo Phillip F. Chance Peter J. Dyck Ma. Theresa Redila-Flores Eric D. Lynch Mitchell S. Golbus Thomas D. Bird Mary Claire King Lee A. Anderson Jeffrey Hall Joop Wiegant Zharong Jiang Paul F. Dazin Hope H. Punnett Steven A. Schonberg Kevin Moore Marcia M. Shull Sandra Gendler Orest Hurko Robert E. Lovelace Norman Latov James Trofatter P. Michael Conneally 《Human genetics》1993,91(3):301-301
74.
Andriy Cherkas Kamelija Zarkovic Ana Cipak Gasparovic Morana Jaganjac Lidija Milkovic Orest Abrahamovych 《Free radical research》2018,52(2):135-149
Helicobacter pylori-induced oxidative stress in gastric mucosa (GM) is a milieu for the development of chronic gastritis, duodenal peptic ulcer (DPU), gastric cancer, and a number of extragastric diseases. Because our previous study revealed the accumulation of the protein adducts of lipid peroxidation product 4-hydroxynonenal (HNE) in GM, which persists after eradication of H. pylori, the aim of the study was to test whether Amaranth oil supplementation in addition to standard anti-Helicobacter treatment could prevent such accumulation of HNE in GM in H. pylori-positive DPU patients. Seventy-five patients were randomly split into two groups: group 1 – standard treatment (n?=?39) and group 2 – standard treatment with additional supplementation of 1?ml of concentrated oil from amaranth seeds (Amaranthus cruenthus L., n?=?36). Clinical analysis, including endoscopy with biopsies from antrum and corpus of the stomach were performed before and after the treatment, as was heart rate variability (HRV) recorded, as parameter of systemic, extragastric pathophysiological alterations in DPU patients. Improvement of clinical, endoscopic and histologic manifestations, and successful ulcer healing were observed in both the groups. Moreover, supplementation of amaranth oil in addition to standard anti-H. pylori treatment significantly reduced accumulation of HNE-histidine adducts in GM and increased HRV in DPU patients (p?.05). Therefore, standard treatments of DPU require additional therapeutic approaches, in accordance with integrative medicine principles, aiming to reduce persistence of oxidative stress, as was successfully done in our study by the use of amaranth oil. 相似文献
75.
Lead and uranium were accumulated equally well both in the viable and dry biomass of Streptomyces sp. The process occurred in less than 5 min. Uranium was accumulated selectively from a polymetallic solution containing U, Pb, Cu, Zn, Ni, Co. The optimum pH for the process was 5.0, and the concentration of each metal in the solution was 10(-3) M. Under these conditions, the dry biomass of Streptomyces amounting to 1 mg/cm3 accumulated over 60% of the uranium in the solution. With the same amount of cell wall preparation it was possible to remove from the solution ca. 90% of U. In this case, the accumulated uranium reached 21% of the sorbent dry mass. Electron micrographs show that lead accumulated in Streptomyces cells is mainly concentrated in the cell wall structures although in the case of uranium this is not so clear. 相似文献
76.
77.
Colin D. MacCalman Riaz Farookhi Orest W. Blaschuk 《Genesis (New York, N.Y. : 2000)》1995,16(1):20-24
N-cadherin (N-cad) is a calcium-dependent cell adhesion molecule which is present in the granulosa cells of the mouse ovarian follicle. This cell adhesion molecule has been implicated as a key modulator of follicular development. The regulators of N-cad mRNA levels in the ovary have not been identified. We have examined the ability of steroids to influence ovarian N-cad mRNA levels in vivo. Immature mice were injected with either progesterone, testosterone, 17β-estradiol, or 17α-estradiol. Only 17β-estradiol caused a rapid and significant increase in the ovarian N-cad mRNA levels. We speculate that this steroid is a major regulator of N-cad-mediated granulosa cell interactions in vivo. © 1995 Wiley-Liss, Inc. 相似文献
78.
79.
The last fifteen years have witnessed a major strategic shift in drug discovery away from an empiric approach based on incremental improvements of proven therapies, to a more theoretical, target-based approach. This arose as a consequence of three technical advances: (1) generation and interpretation of genome sequences, which facilitated identification and characterization of potential drug targets; (2) efficient production of candidate ligands for these putative targets through combinatorial chemistry or generation of monoclonal antibodies; and (3) high-throughput screening for rapid evaluation of interactions of these putative ligands with the selected targets. The basic idea underlying all three of these technologies is in keeping with Marshall Nirenberg’s dictum that science progresses best when there are simple assays capable of generating large data sets rapidly. Furthermore, practical implementation of target-based drug discovery was enabled directly by technologies that either were originated or nurtured by Marshall, his post-docs and fellows. Chief among these was the genetic code. Also important was adoption of clonal cell lines for pharmacological investigations, as well as the use of hybridomas to generate molecular probes that allowed physical purchase on signaling elements that had previously been only hypothetical constructs. Always the pure scientist, Marshall’s contributions nevertheless enabled fruitful applications in the pharmaceutical industry, several of them by his trainees. Both the successes and the shortcomings of target-based drug discovery are worthy of consideration, as are its implications for the choices of therapeutic goals and modalities by the pharmaceutical industry. 相似文献
80.
Roger V. Lebo Phillip F. Chance Peter J. Dyck Ma. Theresa Redila-Flores Eric D. Lynch Mitchell S. Golbus Thomas D. Bird Mary Claire King Lee A. Anderson Jeffrey Hall Joop Wiegant Zharong Jiang Paul F. Dazin Hope H. Punnett Steven A. Schonberg Kevin Moore Marcia M. Shull Sandra Gendler Orest Hurko Robert E. Lovelace Norman Latov James Trofatter P. Michael Conneally 《Human genetics》1993,91(3):301